4
Changes in Ownership
Seres Therapeutics, Inc. Filed Acc 0000899243-16-028243
Chief Technology Officer & EVP sold 9,390 shares at $10.87 ($102,069)
From the SEC's structured data for this filing
Trades in this filing
Aunins John G. · Chief Technology Officer & EVP
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-08-29 | Sale : show line 1 in the form | −9,390 | $10.87 | $102,069 | 192,125 | D |
| Open-market sales · 9,390 sh · avg $10.87 · $102,069 | ||||||
Loading xslF345X03/doc4.xml…